Clinical Trial Update: Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rivaroxaban to fondaparinux for superficial vein thrombosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Vein Thrombosis

Drugs mentioned

• Fondaparinux (fondaparinux)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Superficial Vein Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2023-05-15